Aemetis India Subsidiary Begins Biodiesel Deliveries Under $17 Million Allocation from OMCs
Rhea-AI Summary
Aemetis (NASDAQ: AMTX) reported that its India subsidiary, Universal Biofuels, has secured allocations to deliver more than 18 million liters of biodiesel over three months to India’s three government-owned Oil Marketing Companies, which is expected to generate about $17 million in revenue. Universal is also supplying distilled biodiesel to private commercial customers, with further OMC orders anticipated in 2026 as India targets increasing biodiesel blending from 1% to 5% by 2030.
Universal Biofuels, described as one of India’s largest biodiesel producers, has expanded capacity at its Kakinada plant to about 80 million gallons per year using a proprietary enzymatic process. The subsidiary is exploring additional India locations, new renewable fuels, and preparing for a potential minority-stake IPO on an India stock exchange, subject to market conditions.
Positive
- $17 million expected revenue from OMC biodiesel allocations over three months
- Allocation exceeds 18 million liters of biodiesel to India’s three OMCs
- India biodiesel plant capacity expanded to about 80 million gallons per year
- Universal Biofuels operating in India biodiesel market for more than 18 years
- Preparing potential IPO of Universal Biofuels minority stake on India stock exchange
Negative
- None.
News Explained
As of
Market reaction after India biodiesel contract award: AMTX +4.93%
Following this news, AMTX has gained 4.93%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 2 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $1.59.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 23 | Earnings call notice | Neutral | +8.2% | Scheduled Q2 2026 earnings review; shares rose 8.19%. |
| Jul 09 | Tax credit sale | Positive | -4.5% | Sold $18 million of Section 45Z credits; shares fell 4.55%. |
| Jun 17 | Plant equipment delivery | Positive | -1.0% | Received MVR equipment for ethanol facility; shares fell 1.03%. |
| May 21 | Financing resolution | Positive | +4.7% | Initial resolution supported potential tax-exempt bond issuance; shares rose 4.65%. |
| May 07 | Quarterly earnings | Negative | -3.7% | Reported revenue growth but continued net loss; shares fell 3.70%. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AMTX's recent history showed negative reactions after two positive operational or financial announcements, alongside positive reactions to procedural or financing news.
Key Terms
distilled biodiesel technical
carbon-intensity technical
enzymatic process technical
initial public offering financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
CUPERTINO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, secured allocations to supply more than 18 million liters of biodiesel to India’s three government-owned Oil Marketing Companies (OMCs) during a three-month period, which is expected to generate approximately
In addition to OMC customers, Universal is supplying private commercial customers with distilled biodiesel. Additional OMC fuel supply orders are anticipated before the end of calendar year 2026 to support the India government’s goal of increasing biodiesel blending from
“Universal Biofuels and other biodiesel producers are working with the government of India to build and expand a robust biodiesel industry,” stated Sanjeev Duggal, CEO of Universal Biofuels.
“The increased cost of crude oil has resulted in multiple diesel price increases in India, which supports the India government’s biodiesel blending target of more than 1.2 billion gallons per year,” stated Eric McAfee, Chairman and CEO of Aemetis. “Our Universal Biofuels subsidiary is a leader in producing and delivering high-quality renewable biodiesel and pharma-grade glycerin from our India plant.”
The Universal Biofuels subsidiary of Aemetis is one of the largest biodiesel producers in India and has been in operation for more than 18 years. Universal Biofuels has significantly expanded the production capacity of its Kakinada biodiesel plant to approximately 80 million gallons per year, including expansion of its proprietary enzymatic process to produce lower carbon-intensity biodiesel at reduced cost.
Universal Biofuels is exploring opportunities to expand to other locations throughout India, including diversification into the production of other renewable fuels such as dairy biogas, ethanol, and sustainable aviation fuel. To support this growth, Universal Biofuels is preparing to undertake a potential Initial Public Offering (IPO) for a sale of a minority equity stake to public investors on the India stock exchange, subject to market conditions.
About Aemetis
Headquartered in Cupertino, California, Aemetis is a renewable natural gas and renewable fuel company focused on the operation, acquisition, development, and commercialization of innovative technologies that lower energy costs and reduce emissions while creating new investment and jobs. Founded in 2006, Aemetis is operating and actively expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates an 80 million gallon per year production facility on the East Coast of India producing high-quality distilled biodiesel and refined glycerin. Aemetis is developing a sustainable aviation fuel plant and a CO2 sequestration project in California. For additional information about Aemetis, please visit www.aemetis.com.
Company Investor Relations
Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com
External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements include, without limitation, projections of financial results; statements related to the development, engineering, financing, construction and operation of the Aemetis biodiesel and other biofuel facilities; our ability to promote, develop, finance, and construct facilities to produce biodiesel, renewable fuels, and biochemicals; and statements about future market prices and results of government actions. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “view,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Reports on Form 10-K, and in our other filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
